NEWPORT BEACH, Calif.--(BUSINESS WIRE)--The National Genecular Institute (NGI) today announced Dr. Tannin Fuja, director of research and chief scientific officer, will address how a new, global biobank can advance development of customized medicine for skin cancers and related conditions, while enabling research into major known diseases through a unique global biomedical research protocol that ensures a diverse supply of cellular material. Dr. Fuja will be joined by NGI CEO Matt Nicosia at the 2nd Annual Personalized Medicine Meeting. Dr. Fuja will be speaking about the value of the biobank and customized therapies in preventative medicine.
